HU-x Synthetic Cannabinoids Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 75 studies associated with HU-x Synthetic Cannabinoids.
Here is a small sampling of HU-x Synthetic Cannabinoids studies by title:
- Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia
- The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis
- Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye
- Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury
- Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
Components of the HU-x Synthetic Cannabinoids Research Dashboard
- Top medical conditions associated with HU-x Synthetic Cannabinoids
- Proven effects in clinical trials for HU-x Synthetic Cannabinoids
- Receptors associated with HU-x Synthetic Cannabinoids
- Individual study details for HU-x Synthetic Cannabinoids
Ready to become a subscriber? Go to our PRICING page.
Page Quick Links
Select New Cannabinoid
Overview - HU-x Synthetic Cannabinoids
Description of HU-x Synthetic Cannabinoids
The HU-x series are synthetic cannabinoids that carry the initials based on their place of discovery Hebrew University, Israel. For instance, HU-210 was discovered in 1988.Other Names:
HU Family Synthetic Cannabinoids Dexanabinol (HU-211)HU-x Synthetic Cannabinoids Properties and Effects
Binds with PPAR-? and initiates anti-inflammatory responses.HU-x Synthetic Cannabinoids Receptor Binding
Very strong affinity at mean Ki at human CB1 ~0.25nM (100 times more potent than THC). Very strong affinity for CB2 with a mean Ki at human CB2 is ~0.40nM (86 times more potent than THC)Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.